These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 25636172)

  • 21. High Ki-67 expression in diffuse large B-cell lymphoma patients with non-germinal center subtype indicates limited survival benefit from R-CHOP therapy.
    Li ZM; Huang JJ; Xia Y; Zhu YJ; Zhao W; Wei WX; Jiang WQ; Lin TY; Huang HQ; Guan ZZ
    Eur J Haematol; 2012 Jun; 88(6):510-7. PubMed ID: 22413767
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The novel triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid (CDDO) induces apoptosis of human diffuse large B-cell lymphoma cells through a peroxisome proliferator-activated receptor gamma-independent pathway.
    Ray DM; Morse KM; Hilchey SP; Garcia TM; Felgar RE; Maggirwar SB; Phipps RP; Bernstein SH
    Exp Hematol; 2006 Sep; 34(9):1202-11. PubMed ID: 16939813
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extranodal and nodal diffuse large B cell lymphoma of the head and neck: two different entities?
    Sánchez LA; Redondo AM; Muñez OB; Sebastián E; Alcoceba M; González M; Martín A; Caballero D
    Ann Hematol; 2015 Apr; 94(4):609-16. PubMed ID: 25537456
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of TNF-receptor associated factor 2 correlates with poor progression-free survival time in ABC-like primary nodal diffuse large B-cell lymphomas.
    van Galen JC; Muris JJ; Giroth CP; Vos W; Ossenkoppele GJ; Meijer CJ; Oudejans JJ
    Histopathology; 2008 Apr; 52(5):578-84. PubMed ID: 18312353
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low lymphocyte-to-monocyte ratio predicts unfavorable prognosis in non-germinal center type diffuse large B-cell lymphoma.
    Wei X; Huang F; Wei Y; Jing H; Xie M; Hao X; Feng R
    Leuk Res; 2014 Jun; 38(6):694-8. PubMed ID: 24713260
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Histone deacetylase inhibition down-regulates cyclin D1 transcription by inhibiting nuclear factor-kappaB/p65 DNA binding.
    Hu J; Colburn NH
    Mol Cancer Res; 2005 Feb; 3(2):100-9. PubMed ID: 15755876
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activating mutations affecting the NF-kappa B pathway and EZH2-mediated epigenetic regulation are rare events in primary mediastinal large B-cell lymphoma.
    Gebauer N; Hardel TT; Gebauer J; Bernard V; Merz H; Feller AC; Rades D; Biersack H; Lehnert H; Thorns C
    Anticancer Res; 2014 Oct; 34(10):5503-7. PubMed ID: 25275047
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The alternative NF-kappaB pathway from biochemistry to biology: pitfalls and promises for future drug development.
    Dejardin E
    Biochem Pharmacol; 2006 Oct; 72(9):1161-79. PubMed ID: 16970925
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Addition of rituximab to standard chemotherapy improves the survival of both the germinal center B-cell-like and non-germinal center B-cell-like subtypes of diffuse large B-cell lymphoma.
    Fu K; Weisenburger DD; Choi WW; Perry KD; Smith LM; Shi X; Hans CP; Greiner TC; Bierman PJ; Bociek RG; Armitage JO; Chan WC; Vose JM
    J Clin Oncol; 2008 Oct; 26(28):4587-94. PubMed ID: 18662967
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Upregulation of nuclear transporter, Kpnβ1, contributes to accelerated cell proliferation- and cell adhesion-mediated drug resistance (CAM-DR) in diffuse large B-cell lymphoma.
    He S; Miao X; Wu Y; Zhu X; Miao X; Yin H; He Y; Li C; Liu Y; Lu X; Chen Y; Wang Y; Xu X
    J Cancer Res Clin Oncol; 2016 Mar; 142(3):561-72. PubMed ID: 26498772
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chromosome instability in diffuse large B cell lymphomas is suppressed by activation of the noncanonical NF-κB pathway.
    Ramachandiran S; Adon A; Guo X; Wang Y; Wang H; Chen Z; Kowalski J; Sunay UR; Young AN; Brown T; Mar JC; Du Y; Fu H; Mann KP; Natkunam Y; Boise LH; Saavedra HI; Lossos IS; Bernal-Mizrachi L
    Int J Cancer; 2015 May; 136(10):2341-51. PubMed ID: 25359525
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IκB-ζ controls the constitutive NF-κB target gene network and survival of ABC DLBCL.
    Nogai H; Wenzel SS; Hailfinger S; Grau M; Kaergel E; Seitz V; Wollert-Wulf B; Pfeifer M; Wolf A; Frick M; Dietze K; Madle H; Tzankov A; Hummel M; Dörken B; Scheidereit C; Janz M; Lenz P; Thome M; Lenz G
    Blood; 2013 Sep; 122(13):2242-50. PubMed ID: 23869088
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic value of nuclear factor κ B expression in patients with advanced cervical cancer undergoing radiation therapy followed by hysterectomy.
    Baiocchi G; Begnami MD; Fukazawa EM; Oliveira RA; Faloppa CC; Kumagai LY; Badiglian-Filho L; Pellizzon AC; Maia MA; Jacinto AA; Soares FA; Lopes A
    J Clin Pathol; 2012 Jul; 65(7):614-8. PubMed ID: 22447917
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Piperlongumine selectively suppresses ABC-DLBCL through inhibition of NF-κB p65 subunit nuclear import.
    Niu M; Shen Y; Xu X; Yao Y; Fu C; Yan Z; Wu Q; Cao J; Sang W; Zeng L; Li Z; Liu X; Xu K
    Biochem Biophys Res Commun; 2015 Jul; 462(4):326-31. PubMed ID: 25979358
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nuclear factor-kappaB p65 is a prognostic indicator in gastric carcinoma.
    Yamanaka N; Sasaki N; Tasaki A; Nakashima H; Kubo M; Morisaki T; Noshiro H; Yao T; Tsuneyoshi M; Tanaka M; Katano M
    Anticancer Res; 2004; 24(2C):1071-5. PubMed ID: 15154625
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of nuclear factor-κB regulators TNFAIP3 and CARD11 in Middle Eastern diffuse large B-cell lymphoma.
    Bu R; Bavi P; Abubaker J; Jehan Z; Al-Haqawi W; Ajarim D; Al-Dayel F; Uddin S; Al-Kuraya KS
    Leuk Lymphoma; 2012 Oct; 53(10):1971-7. PubMed ID: 22397314
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nuclear factor-κB activation in primary lymphoma of bone.
    Koens L; Heyning FH; Szepesi A; Matolcsy A; Hogendoorn PC; Jansen PM
    Virchows Arch; 2013 Mar; 462(3):349-54. PubMed ID: 23328932
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A20 Mutation Is Not a Prognostic Marker for Activated B-Cell-Like Diffuse Large B-Cell Lymphoma.
    Cen H; Tan X; Guo B
    PLoS One; 2015; 10(12):e0145037. PubMed ID: 26716984
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sites of extranodal involvement are prognostic in patients with diffuse large B-cell lymphoma in the rituximab era: an analysis of the Surveillance, Epidemiology and End Results database.
    Castillo JJ; Winer ES; Olszewski AJ
    Am J Hematol; 2014 Mar; 89(3):310-4. PubMed ID: 24273125
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MiR-17∼92 is involved in NF-κB activation via targeting the ubiquitin-editing proteins to mediate RIP1 complex polyubiquitinations in ABC-DLBCL.
    Zhang X; Zhang X; Huang X; Iqbal J; McKeithan TW; Chan WC; Vose JM; Bi C; Zhu X; Fu K
    Clin Immunol; 2024 Aug; 265():110297. PubMed ID: 38909971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.